multi-CAR-T cell therapy
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 12, 2020
Multi-CAR-T Cells Targeting B Cell Lymphomas
(clinicaltrials.gov)
- P1/2; N=11; Recruiting; Sponsor: Shenzhen Geno-Immune Medical Institute
CAR T-Cell Therapy • New P1/2 trial • Hematological Disorders • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1